Terms: = Pancreatic cancer AND MYO5A, Q9Y4I1, MYR12, MYO5, MYH12, GS1, ENSG00000197535, 4644
3 results:
1. miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer.
Machida T; Tomofuji T; Maruyama T; Yoneda T; Ekuni D; Azuma T; Miyai H; Mizuno H; Kato H; Tsutsumi K; Uchida D; Takaki A; Okada H; Morita M
Oncol Rep; 2016 Oct; 36(4):2375-81. PubMed ID: 27573701
[TBL] [Abstract] [Full Text] [Related]
2. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z
Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110
[TBL] [Abstract] [Full Text] [Related]
3. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
[TBL] [Abstract] [Full Text] [Related]
